Recurrent Seizures and Serotonin Syndrome Following “2C-I” Ingestion (original) (raw)

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The phenethylamines, including 2, 5 dimethoxy-4-iodophenethylamine, commonly referred to as 2C-I, have recently emerged as a new class of designer drugs. Cases of toxicity from these drugs are not well described in the literature. This case report describes a 19 year-old male who insufflated 2C-I. Following the ingestion, the patient developed recurrent seizures, and was taken to the emergency department, where he was noted to be hyperadrenergic and had recurrent seizures. The patient was diagnosed with serotonin syndrome and experienced prolonged respiratory failure, although he ultimately made a full recovery. Comprehensive drug testing revealed the presence of 2C-I. The pharmacologic properties of 2C-I are also discussed.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Haroz R, Greenberg MI (2005) Emerging drugs of abuse. Med Clin N Am 89:1259–76
    Article PubMed CAS Google Scholar
  2. Andreasen MF, Telving R, Birkler RI et al (2009) A fatal poisoning involving Bromo-Dragonfly. Forensic Sci Int 183:91–6
    Article PubMed CAS Google Scholar
  3. Theobald DS, Pütz M, Schneider E et al (2006) New designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic-mass spectrometric and capillary electrophoretic/mass spectrometric techniques. J Mass Spectrom 41:872–86
    Article PubMed CAS Google Scholar
  4. Johnson MP, Mathis CA, Shuligin AT et al (1990) [125I]-2-(2, 5-Dimethoxy-4-iodophenyl)aminoethane ([125]-2C-I) as a label for the 5HT2 receptor in rat frontal cortex. Pharmacol Biochem Behav 35:211–7
    Article PubMed CAS Google Scholar
  5. Castillo AC, Villalobos C, Moya PR et al (2002) Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5HT2A and 5HT2C receptors. Br J Pharmacol 136:510–9
    Article Google Scholar
  6. Nagai F, Nonaka R, Satoh Hisashi Kamimura K (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559:132–7
    Article PubMed CAS Google Scholar
  7. Maurer HH (2010) Chemistry, pharmacology, and metabolism of emerging drugs of abuse. Ther Drug Monit 32:544–9
    Article PubMed CAS Google Scholar
  8. Theobald DS, Maurer HH (2007) Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2c-series). Biochem Pharmacol 73:287–97
    Article PubMed CAS Google Scholar
  9. Drug Enforcement Administration, Office of Forensic Sciences. Microgram Bulletin. US Department of Justice, Drug Enforcement Administration. 2004; 38:48-9
    Google Scholar
  10. DeBoer D, Gijzeles MJ, Bosman IJ et al (1999) More data about the new psychoactive drug 2C-B. J Anal Toxicol 23:227–8
    Article CAS Google Scholar
  11. Boyer EW, Shannon M (2005) The serotonin syndrome. N Engl J Med 352:1112–20
    Article PubMed CAS Google Scholar
  12. Dunkey EJ, Isbister GK, Sibbritt D et al (2003) The Hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 96:635–42
    Article Google Scholar
  13. Kirshner R, Donovan JW (2010) Serotonin syndrome precipitated by fentanyl during procedural sedation. J Emerg Med 38:477–80
    Article Google Scholar

Download references

Disclosures

There are no financial, litigational, or other conflicts of interest to disclose.

Author information

Authors and Affiliations

  1. Department of Medical Toxicology, Banner Good Samaritan Medical Center, Phoenix, AZ, USA
    Adam Bosak, Frank LoVecchio & Michael Levine
  2. Department of Emergency Medicine, Section of Medical Toxicology, University of Southern California, Los Angeles, CA, USA
    Michael Levine

Authors

  1. Adam Bosak
    You can also search for this author inPubMed Google Scholar
  2. Frank LoVecchio
    You can also search for this author inPubMed Google Scholar
  3. Michael Levine
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toMichael Levine.

Rights and permissions

About this article

Cite this article

Bosak, A., LoVecchio, F. & Levine, M. Recurrent Seizures and Serotonin Syndrome Following “2C-I” Ingestion.J. Med. Toxicol. 9, 196–198 (2013). https://doi.org/10.1007/s13181-013-0287-x

Download citation

Keywords